Publicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (2)

2022

  1. Consensus on early detection of disease progression in patients with multiple sclerosis

    Frontiers in Neurology, Vol. 13

2020

  1. Effectiveness of fingolimod versus natalizumab as second-line therapy for relapsing-remitting multiple sclerosis in Spain: Second-Line GATE study

    European Neurology, Vol. 83, Núm. 1, pp. 25-33